How Valisure is Disrupting Big Pharma’s Quality Control Systems

With the pharmaceutical industry in the USA predicted to rise to $9.7 billion by 2027, quality control will be key to maintaining public safety for pharmaceutical use. Anthony Lacavera sits down with David Light, CEO of Valisure to discover how his company batch tests medications to ensure therapeutic effectiveness, predictable performance, and safety.